LLY · News · 20261030N
Guidance and Outlook
ELI LILLY & Co · 2026-10-30 · Importance 75 · Surprise 60 · In source text
Eli Lilly raised its 2026 revenue outlook to $91 billion-$92 billion. The range reflects management’s forward view for the full year; the digest does not specify a timeframe for the increase beyond 2026. The outlook is material relative to the company’s revenue threshold.
Key facts
- Eli Lilly raised its full-year revenue guidance to between $91 billion and $92 billion. source
- Wells Fargo's fiscal 2026 revenue estimate of $92 billion aligned with the high end of Eli Lilly's guidance. source
- Wells Fargo increased its price target for Eli Lilly shares from $1,330 to $1,500 and maintained an Overweight rating. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Eli Lilly raised its full-year revenue guidance to between $91 billion and $92 billion. |